Arta Monir Monjazeb

Title(s)Professor in Residence, MED: Radiation-Oncology
SchoolSchool of Medicine
Address4501 X Street, G-120
CA 95817
Phone916-734-5823
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Student Projects

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO). Lancet Oncol. 2024 Oct; 25(10):e489-e500. Zumsteg ZS, Sheth S, Jabbour SK, Patel KR, Kimple RJ, Williams TM, Xu-Welliver M, Torres-Saavedra PA, Monjazeb AM, Mayadev J, Finkelstein SE, Buatti JM, Patel SP, Lin SH. PMID: 39362260.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Systemic immunostimulation induces glucocorticoid-mediated thymic involution succeeded by rebound hyperplasia which is impaired in aged recipients. Front Immunol. 2024; 15:1429912. Collins CP, Khuat LT, Sckisel GD, Vick LV, Minnar CM, Dunai C, Le CT, Curti BD, Crittenden M, Merleev A, Sheng M, Chao NJ, Maverakis E, Rosario SR, Monjazeb AM, Blazar BR, Longo DL, Canter RJ, Murphy WJ. PMID: 39315105; PMCID: PMC11416920.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    3. Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study. JTO Clin Res Rep. 2024 Oct; 5(10):100706. Riess JW, Lara MS, Lopez de Rodas M, Luxardi G, Herbert S, Shimoda M, Kelly K, Meerlev A, Moore E, Beckett L, Monjazeb A, Schalper K, Maverakis E, Gandara DR. PMID: 39318388; PMCID: PMC11420451.
      View in: PubMed   Mentions:
    4. Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma. J Surg Oncol. 2024 Sep; 130(3):543-551. Garibay ER, Cruz SM, Judge SJ, Monjazeb AM, Thorpe SW, Murphy WJ, Lyu J, Chen S, Bateni CP, Canter RJ. PMID: 39402905.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox. NPJ Metab Health Dis. 2024; 2(1):5. Vick LV, Rosario S, Riess JW, Canter RJ, Mukherjee S, Monjazeb AM, Murphy WJ. PMID: 38800540; PMCID: PMC11116109.
      View in: PubMed   Mentions:
    6. Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas. Semin Radiat Oncol. 2024 Apr; 34(2):243-257. Su C, Kim SK, Wang CX, Kirsch DG, Monjazeb AM. PMID: 38508788; PMCID: PMC11216412.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue Sarcomas. Int J Mol Sci. 2024 Mar 15; 25(6). Cruz SM, Iranpur KR, Judge SJ, Ames E, Sturgill IR, Farley LE, Darrow MA, Crowley JS, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 38542325; PMCID: PMC10969893.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Post-death Vesicles of Senescent Bone Marrow Mesenchymal Stromal Polyploids Promote Macrophage Aging and Breast Cancer. bioRxiv. 2024 Mar 08. Xie B, Fan M, Wang CX, Zhang Y, Xu S, Mizenko R, Lin TY, Duan Y, Zhang Y, Huang J, Berg JI, Wu D, Li A, Hao D, Gao K, Sun Y, Tepper CG, Carney R, Li Y, Wang A, Gong Q, Daly M, Jao LE, Monjazeb AM, Fierro FA, Li JJ. PMID: 38496556; PMCID: PMC10942423.
      View in: PubMed   Mentions:
    9. Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma. Invest New Drugs. 2024 Feb; 42(1):35-43. Huynh JC, Cho M, Monjazeb A, Al-Obeidi E, Singh A, Tam K, Lara F, Martinez A, Garcia L, Kim EJ. PMID: 38038862; PMCID: PMC10891185.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    10. Scrutinizing the use of contrasted chest CTs in extremity sarcoma staging and surveillance. J Surg Oncol. 2024 Mar; 129(3):523-530. Priester JI, Simister SK, Sario M, Choi J, Pina D, Theriault R, Bateni C, Ghasemiesfe A, Carr-Ascher J, Monjazeb AM, Canter RJ, Randall RL, Thorpe SW. PMID: 37997294.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Regulation of human and mouse bystander T cell activation responses by PD-1. JCI Insight. 2023 09 22; 8(18). Le CT, Vick LV, Collins C, Dunai C, Sheng MK, Khuat LT, Barao I, Judge SJ, Aguilar EG, Curti B, Dave M, Longo DL, Blazar BR, Canter RJ, Monjazeb AM, Murphy WJ. PMID: 37737264; PMCID: PMC10561715.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    12. Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial. Nat Commun. 2023 09 02; 14(1):5332. Monjazeb AM, Daly ME, Luxardi G, Maverakis E, Merleev AA, Marusina AI, Borowsky A, Mirhadi A, Shiao SL, Beckett L, Chen S, Eastham D, Li T, Vick LV, McGee HM, Lara F, Garcia L, Morris LA, Canter RJ, Riess JW, Schalper KA, Murphy WJ, Kelly K. PMID: 37658083; PMCID: PMC10474145.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    13. Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data. Semin Cancer Biol. 2023 10; 95:88-102. Vick LV, Canter RJ, Monjazeb AM, Murphy WJ. PMID: 37499846; PMCID: PMC10836337.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Intratumoral NKp46+ natural killer cells are spatially distanced from T and MHC-I+ cells with prognostic implications in soft tissue sarcoma. Front Immunol. 2023; 14:1230534. Cruz SM, Sholevar CJ, Judge SJ, Darrow MA, Iranpur KR, Farley LE, Lammers M, Razmara AM, Dunai C, Gingrich AA, Persky J, Mori H, Thorpe SW, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 37545516; PMCID: PMC10401426.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    15. Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. Int J Mol Sci. 2023 Jun 29; 24(13). Rosario SR, Dong B, Zhang Y, Hsiao HH, Isenhart E, Wang J, Siegel EM, Monjazeb AM, Owen DH, Dey P, Tabung FK, Spakowicz DJ, Murphy WJ, Edge S, Yendamuri S, Ibrahimi S, Kolesar JM, McDonald PH, Vadehra D, Churchman M, Liu S, Kalinski P, Mukherjee S. PMID: 37446025; PMCID: PMC10342094.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    16. Advances in Radiotherapy Immune Modulation: From Bench-to-Bedside and Back Again. Surg Oncol Clin N Am. 2023 07; 32(3):617-629. Wang CX, Hunt J, Feinstein S, Kim SK, Monjazeb AM. PMID: 37182996.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the "obesity paradox". Front Immunol. 2022; 13:1012016. Vick LV, Collins CP, Khuat LT, Wang Z, Dunai C, Aguilar EG, Stoffel K, Yendamuri S, Smith R, Mukherjee S, Barbi J, Canter RJ, Monjazeb AM, Murphy WJ. PMID: 36776393; PMCID: PMC9910174.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    18. Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. J Immunother Cancer. 2023 01; 11(1). Perry LM, Cruz SM, Kleber KT, Judge SJ, Darrow MA, Jones LB, Basmaci UN, Joshi N, Settles ML, Durbin-Johnson BP, Gingrich AA, Monjazeb AM, Carr-Ascher J, Thorpe SW, Murphy WJ, Eisen JA, Canter RJ. PMID: 36599469; PMCID: PMC9815021.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    19. Intralesional interleukin-2 augmentation therapy in treatment-refractory melanoma. Dermatol Ther. 2022 11; 35(11):e15853. Le ST, Ji-Xu A, Liakos W, Toussi AM, Cheng MY, Ma C, Wang EA, Wilken R, Boddu S, Downing L, Kao J, Davis JR, Monjazeb AM, Fung MA, Konia TH, Maverakis E, Kirane AR. PMID: 36151592.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Head and Neck Cutaneous Soft-Tissue Sarcoma Demonstrate Sex and Racial/Ethnic Disparities in Incidence and Socioeconomic Disparities in Survival. J Clin Med. 2022 Sep 17; 11(18). Jawad MU, Zeitlinger LN, Bewley AF, O'Donnell EF, Traven SA, Carr-Ascher JR, Monjazeb AM, Canter RJ, Thorpe SW, Randall RL. PMID: 36143122; PMCID: PMC9501210.
      View in: PubMed   Mentions:
    21. Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas. Front Immunol. 2022; 13:893177. Judge SJ, Bloomstein JD, Sholevar CJ, Darrow MA, Stoffel KM, Vick LV, Dunai C, Cruz SM, Razmara AM, Monjazeb AM, Rebhun RB, Murphy WJ, Canter RJ. PMID: 35874727; PMCID: PMC9300876.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    22. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 2022 03 21; 13(1):1511. Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, Hamsafar Y, Evans AC, Huang J, Zhou W, Lin X, Ye N, Wanggou S, Chen W, Jing D, Fragoso RC, Dugger BN, Wilson PF, Coleman MA, Xia S, Li X, Sun LQ, Monjazeb AM, Wang A, Murphy WJ, Kung HJ, Lam KS, Chen HW, Li JJ. PMID: 35314680; PMCID: PMC8938495.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    23. Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial. Lancet Oncol. 2022 02; 23(2):279-291. Schoenfeld JD, Giobbie-Hurder A, Ranasinghe S, Kao KZ, Lako A, Tsuji J, Liu Y, Brennick RC, Gentzler RD, Lee C, Hubbard J, Arnold SM, Abbruzzese JL, Jabbour SK, Uboha NV, Stephans KL, Johnson JM, Park H, Villaruz LC, Sharon E, Streicher H, Ahmed MM, Lyon H, Cibuskis C, Lennon N, Jhaveri A, Yang L, Altreuter J, Gunasti L, Weirather JL, Mak RH, Awad MM, Rodig SJ, Chen HX, Wu CJ, Monjazeb AM, Hodi FS. PMID: 35033226; PMCID: PMC8813905.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    24. Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects. Blood. 2021 12 16; 138(24):2583-2588. Khuat LT, Vick LV, Dunai C, Collins CP, More SK, Le CT, Pai CS, Stoffel KM, Maverakis E, Canter RJ, Monjazeb AM, Longo DL, Abedi M, Choi E, Blazar BR, Dave M, Murphy WJ. PMID: 34424962; PMCID: PMC8678998.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    25. T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma. Front Vet Sci. 2021; 8:772932. Sparger EE, Chang H, Chin N, Rebhun RB, Withers SS, Kieu H, Canter RJ, Monjazeb AM, Kent MS. PMID: 34926643; PMCID: PMC8674490.
      View in: PubMed   Mentions: 6  
    26. Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice. Front Immunol. 2021; 12:752484. Khuat LT, Vick LV, Choi E, Dunai C, Merleev AA, Maverakis E, Blazar BR, Monjazeb AM, Murphy WJ. PMID: 34707616; PMCID: PMC8542879.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    27. Surgical and oncologic outcomes following arterial resection and reconstruction for advanced solid tumors. J Surg Oncol. 2021 Dec; 124(8):1251-1260. Cruz SM, Basmaci UN, Bateni CP, Darrow MA, Judge SJ, Monjazeb AM, Thorpe SW, Humphries MD, Canter RJ. PMID: 34495553.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2021 Sep 01; 27(17):4940. Monjazeb AM, Giobbie-Hurder A, Lako A, Thrash EM, Brennick RC, Kao KZ, Manuszak C, Gentzler RD, Tesfaye A, Jabbour SK, Alese OB, Rahma OE, Cleary JM, Sharon E, Mamon HJ, Cho M, Streicher H, Chen HX, Ahmed MM, Mariño-Enríquez A, Kim-Schulze S, Gnjatic S, Maverakis E, Marusina AI, Merleev AA, Severgnini M, Pfaff KL, Lindsay J, Weirather JL, Ranasinghe S, Spektor A, Rodig SJ, Hodi FS, Schoenfeld JD. PMID: 34470811.
      View in: PubMed   Mentions: 1     Fields:    
    29. Parallels Between the Antiviral State and the Irradiated State. J Natl Cancer Inst. 2021 08 02; 113(8):969-979. McGee HM, Marciscano AE, Campbell AM, Monjazeb AM, Kaech SM, Teijaro JR. PMID: 33252657; PMCID: PMC8502484.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    30. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? J Immunother Cancer. 2021 04; 9(4). Demaria S, Guha C, Schoenfeld J, Morris Z, Monjazeb A, Sikora A, Crittenden M, Shiao S, Khleif S, Gupta S, Formenti SC, Vikram B, Coleman CN, Ahmed MM. PMID: 33827904; PMCID: PMC8031689.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimals
    31. A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2021 05 01; 27(9):2470-2480. Monjazeb AM, Giobbie-Hurder A, Lako A, Thrash EM, Brennick RC, Kao KZ, Manuszak C, Gentzler RD, Tesfaye A, Jabbour SK, Alese OB, Rahma OE, Cleary JM, Sharon E, Mamon HJ, Cho M, Streicher H, Chen HX, Ahmed MM, Mariño-Enríquez A, Kim-Schulze S, Gnjatic S, Maverakis E, Marusina AI, Merleev AA, Severgnini M, Pfaff KL, Lindsay J, Weirather JL, Ranasinghe S, Spektor A, Rodig SJ, Hodi SF, Schoenfeld JD. PMID: 33568343; PMCID: PMC8102320.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    32. Mouse Preclinical Cancer Immunotherapy Modeling Involving Anti-PD-1 Therapies Reveals the Need to Use Mouse Reagents to Mirror Clinical Paradigms. Cancers (Basel). 2021 Feb 10; 13(4). Monjazeb AM, Wang Z, Vick LV, Dunai C, Minnar C, Khuat LT, Murphy WJ. PMID: 33578798; PMCID: PMC7916633.
      View in: PubMed   Mentions: 3  
    33. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation. Sci Transl Med. 2020 11 25; 12(571). Khuat LT, Le CT, Pai CS, Shields-Cutler RR, Holtan SG, Rashidi A, Parker SL, Knights D, Luna JI, Dunai C, Wang Z, Sturgill IR, Stoffel KM, Merleev AA, More SK, Maverakis E, Raybould HE, Chen M, Canter RJ, Monjazeb AM, Dave M, Ferrara JLM, Levine JE, Longo DL, Abedi M, Blazar BR, Murphy WJ. PMID: 33239390; PMCID: PMC8525601.
      View in: PubMed   Mentions: 22     Fields:    Translation:Animals
    34. Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas. J Immunother Cancer. 2020 11; 8(2). Judge SJ, Darrow MA, Thorpe SW, Gingrich AA, O'Donnell EF, Bellini AR, Sturgill IR, Vick LV, Dunai C, Stoffel KM, Lyu Y, Chen S, Cho M, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 33158916; PMCID: PMC7651745.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    35. PD-1 Blockade Reverses Obesity-Mediated T Cell Priming Impairment. Front Immunol. 2020; 11:590568. Le CT, Khuat LT, Caryotakis SE, Wang M, Dunai C, Nguyen AV, Vick LV, Stoffel KM, Blazar BR, Monjazeb AM, Murphy WJ, Soulika AM. PMID: 33193426; PMCID: PMC7658608.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    36. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591. Candas-Green D, Xie B, Huang J, Fan M, Wang A, Menaa C, Zhang Y, Zhang L, Jing D, Azghadi S, Zhou W, Liu L, Jiang N, Li T, Gao T, Sweeney C, Shen R, Lin TY, Pan CX, Ozpiskin OM, Woloschak G, Grdina DJ, Vaughan AT, Wang JM, Xia S, Monjazeb AM, Murphy WJ, Sun LQ, Chen HW, Lam KS, Weichselbaum RR, Li JJ. PMID: 32929084; PMCID: PMC7490264.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    37. Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series. J Natl Compr Canc Netw. 2020 07; 18(7):798-804. Demisse R, Damle N, Kim E, Gong J, Fakih M, Eng C, Oesterich L, McKenny M, Ji J, Liu J, Louie R, Tam K, Gholami S, Halabi W, Monjazeb A, Dayyani F, Cho M. PMID: 32634770.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    38. Radiotherapy is Associated With Improved Survival in Patients With Synovial Sarcoma Undergoing Surgery: A National Cancer Database Analysis. J Surg Res. 2020 11; 255:378-387. Gingrich AA, Marrufo AS, Liu Y, Li CS, Darrow MA, Monjazeb AM, Thorpe SW, Canter RJ. PMID: 32599458.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    39. Minimal PD-1 expression in mouse and human NK cells under diverse conditions. J Clin Invest. 2020 06 01; 130(6):3051-3068. Judge SJ, Dunai C, Aguilar EG, Vick SC, Sturgill IR, Khuat LT, Stoffel KM, Van Dyke J, Longo DL, Darrow MA, Anderson SK, Blazar BR, Monjazeb AM, Serody JS, Canter RJ, Murphy WJ. PMID: 32134744; PMCID: PMC7260004.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimalsCells
    40. MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation. Adv Radiat Oncol. 2020 Nov-Dec; 5(6):1286-1295. Chen H, Shi L, Nguyen KNB, Monjazeb AM, Matsukuma KE, Loehfelm TW, Huang H, Qiu J, Rong Y. PMID: 33305090; PMCID: PMC7718560.
      View in: PubMed   Mentions: 14  
    41. Effects of Radiation on the Tumor Microenvironment. Semin Radiat Oncol. 2020 04; 30(2):145-157. Monjazeb AM, Schalper KA, Villarroel-Espindola F, Nguyen A, Shiao SL, Young K. PMID: 32381294; PMCID: PMC8764968.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    42. Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer. PLoS One. 2020; 15(2):e0224775. Judge SJ, Yanagisawa M, Sturgill IR, Bateni SB, Gingrich AA, Foltz JA, Lee DA, Modiano JF, Monjazeb AM, Culp WTN, Rebhun RB, Murphy WJ, Kent MS, Canter RJ. PMID: 32084139; PMCID: PMC7034869.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCellsCTClinical Trials
    43. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):e372-e377. Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. PMID: 31866577.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clin Colorectal Cancer. 2019 12; 18(4):307-309. Gong J, Robertson MD, Kim E, Fakih M, Schrock AB, Tam KW, Burugapalli B, Monjazeb AM, Hendifar AE, Hitchins M, Klempner SJ, Cho M. PMID: 31563511.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer. Front Immunol. 2019; 10:1940. Naik A, Monjazeb AM, Decock J. PMID: 31475003; PMCID: PMC6703078.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    46. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis. J Surg Oncol. 2019 Sep; 120(4):753-760. Judge SJ, Lata-Arias K, Yanagisawa M, Darrow MA, Monjazeb AM, Kirane AR, Bold RJ, Canter RJ, Canter DJ. PMID: 31355444.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    47. Prospective, Randomized Control Trial Investigating the Impact of a Physician-Communicated Radiation Therapy Plan Review on Breast Cancer Patient-Reported Satisfaction. Pract Radiat Oncol. 2019 Nov; 9(6):e487-e496. Dyer BA, Li CS, Daly ME, Monjazeb AM, Mayadev JS. PMID: 31226443.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer. 2019 08 15; 125(16):2732-2746. George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM. PMID: 31017664; PMCID: PMC6663584.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    49. Role of Radiation Therapy in Adult Extraskeletal Ewing's Sarcoma Patients Treated with Chemotherapy and Surgery. Sarcoma. 2019; 2019:5413527. Saiz AM, Gingrich AA, Canter RJ, Kirane AR, Monjazeb AM, Randall RL, Thorpe SW. PMID: 31178655; PMCID: PMC6507246.
      View in: PubMed   Mentions: 3  
    50. Extremity soft tissue sarcoma in the elderly: Are we overtreating or undertreating this potentially vulnerable patient population? J Surg Oncol. 2019 Jun; 119(8):1087-1098. Gingrich AA, Bateni SB, Monjazeb AM, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. PMID: 30977916.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    51. Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma. Vet Comp Oncol. 2019 Sep; 17(3):242-252. Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. PMID: 30684301; PMCID: PMC6658355.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    52. The complicated effects of  obesity on cancer and immunotherapy. Immunotherapy. 2019 01; 11(1):11-14. Wang Z, Monjazeb AM, Murphy WJ. PMID: 30702013.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    53. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors. Pract Radiat Oncol. 2019 Mar; 9(2):e196-e202. Nguyen KNB, Hause DJ, Novak J, Monjazeb AM, Daly ME. PMID: 30496842; PMCID: PMC6402805.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    54. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019 01; 25(1):141-151. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. PMID: 30420753; PMCID: PMC6324991.
      View in: PubMed   Mentions: 400     Fields:    Translation:HumansAnimalsCells
    55. Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma. Vet Comp Oncol. 2019 Mar; 17(1):49-60. Withers SS, Skorupski KA, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Rodriguez CO, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. PMID: 30156029; PMCID: PMC6363827.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    56. Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation. Theranostics. 2018; 8(13):3611-3628. Chavez M, Silvestrini MT, Ingham ES, Fite BZ, Mahakian LM, Tam SM, Ilovitsh A, Monjazeb AM, Murphy WJ, Hubbard NE, Davis RR, Tepper CG, Borowsky AD, Ferrara KW. PMID: 30026870; PMCID: PMC6037035.
      View in: PubMed   Mentions: 48     Fields:    Translation:Animals
    57. Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs. Dev Comp Immunol. 2018 10; 87:64-74. Withers SS, Moore PF, Chang H, Choi JW, McSorley SJ, Kent MS, Monjazeb AM, Canter RJ, Murphy WJ, Sparger EE, Rebhun RB. PMID: 29859828; PMCID: PMC6197816.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    58. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1259-1270. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. PMID: 29891204; PMCID: PMC6364565.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    59. Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma. Anticancer Res. 2018 03; 38(3):1491-1497. Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold RJ, Monjazeb AM, Canter RJ. PMID: 29491077; PMCID: PMC5836802.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    60. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. J Immunother Cancer. 2018 01 29; 6(1):6. Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM. PMID: 29375032; PMCID: PMC5787916.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    61. T Cells Dominate the Local Immune Response Induced by Intralesional IL-2 in Combination with Imiquimod and Retinoid for In-Transit Metastatic Melanoma. J Invest Dermatol. 2018 06; 138(6):1442-1445. Ogawa H, Luxardi G, Kirane A, Kulkarni R, Monjazeb AM, Cheng MY, Ma C, Maverakis E. PMID: 29291382.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    62. Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. J Surg Res. 2018 03; 223:207-214. Henderson T, Chen M, Darrow MA, Li CS, Chiu CL, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 29433875; PMCID: PMC5812363.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    63. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. J Immunother Cancer. 2017 Dec 19; 5(1):98. Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, Monjazeb AM, Lee DA, Murphy WJ. PMID: 29254507; PMCID: PMC5735903.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    64. From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely. Clin Cancer Res. 2017 09 01; 23(17):4980-4991. Day D, Monjazeb AM, Sharon E, Ivy SP, Rubin EH, Rosner GL, Butler MO. PMID: 28864726; PMCID: PMC5736967.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    65. The Challenge for Development of Valuable Immuno-oncology Biomarkers. Clin Cancer Res. 2017 09 01; 23(17):4970-4979. Mehnert JM, Monjazeb AM, Beerthuijzen JMT, Collyar D, Rubinstein L, Harris LN. PMID: 28864725; PMCID: PMC5657536.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    66. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis. Ann Surg Oncol. 2017 Oct; 24(11):3252-3263. Gingrich AA, Bateni SB, Monjazeb AM, Darrow MA, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. PMID: 28741123; PMCID: PMC5693726.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    67. Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):362-373. Baird JR, Monjazeb AM, Shah O, McGee H, Murphy WJ, Crittenden MR, Gough MJ. PMID: 28871985; PMCID: PMC5604475.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    68. Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy. J Immunother Cancer. 2017; 5:33. Sckisel GD, Mirsoian A, Minnar CM, Crittenden M, Curti B, Chen JQ, Blazar BR, Borowsky AD, Monjazeb AM, Murphy WJ. PMID: 28428882; PMCID: PMC5394626.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    69. Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols. JCI Insight. 2017 03 23; 2(6):e90521. Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci ST, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW. PMID: 28352658; PMCID: PMC5358490.
      View in: PubMed   Mentions: 54     Fields:    Translation:AnimalsCells
    70. Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer. 2016; 4:97. Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WTN, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 28031824; PMCID: PMC5171656.
      View in: PubMed   Mentions: 65     Fields:    
    71. Conservative management of desmoid tumors is safe and effective. J Surg Res. 2016 09; 205(1):115-20. Park JS, Nakache YP, Katz J, Boutin RD, Steffner RJ, Monjazeb AM, Canter RJ. PMID: 27621007.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    72. The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning. Anticancer Res. 2016 Jun; 36(6):3013-7. Miyamoto J, Michaud AL, Harandi NK, Kim EJ, Semrad T, Khatri V, Mayadev J, Perks J, Monjazeb AM. PMID: 27272819.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Older Age Modifies Oncologic Outcome Following Radiotherapy in Soft-tissue Sarcoma: A Subtype-specific SEER Analysis. Anticancer Res. 2016 Apr; 36(4):1745-50. Yuen NK, Li CS, Monjazeb AM, Borys D, Bold RJ, Canter RJ. PMID: 27069154.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clin Cancer Res. 2016 Sep 01; 22(17):4328-40. Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ. PMID: 26979392; PMCID: PMC5010514.
      View in: PubMed   Mentions: 58     Fields:    Translation:AnimalsCells
    75. Radiation dose and checkpoint blockade immunotherapy: unanswered questions. Lancet Oncol. 2016 Jan; 17(1):e3-4. Monjazeb AM, Schoenfeld JD. PMID: 26758758.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    76. Long-Term Progression-Free Survival in a Patient with Locally Advanced, Unresectable Pancreatic Adenocarcinoma. Cureus. 2015 Dec 15; 7(12):e406. Dyer BA, Kahn LA, Matin M, Bold RJ, Tanaka MI, Monjazeb AM. PMID: 26824007; PMCID: PMC4725616.
      View in: PubMed   Mentions:
    77. Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer. J Thorac Oncol. 2015 Dec; 10(12):1685-93. Daly ME, Monjazeb AM, Kelly K. PMID: 26484629.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    78. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol. 2015 Oct 15; 195(8):4010-9. Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. PMID: 26363055; PMCID: PMC4781667.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansAnimalsCells
    79. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016 Feb; 5(2):e1075114. Mall C, Sckisel GD, Proia DA, Mirsoian A, Grossenbacher SK, Pai CS, Chen M, Monjazeb AM, Kelly K, Blazar BR, Murphy WJ. PMID: 27057446; PMCID: PMC4801432.
      View in: PubMed   Mentions: 28     Fields:    
    80. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series. J Am Acad Dermatol. 2015 Oct; 73(4):645-54. Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E. PMID: 26259990.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    81. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity. Immunity. 2015 Aug 18; 43(2):240-50. Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E, Mirsoian A, Reddy A, Alexander W, Soulika A, Blazar BR, Longo DL, Wiltrout RH, Murphy WJ. PMID: 26231116; PMCID: PMC4770886.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    82. Older age impacts radiotherapy-related outcomes in soft tissue sarcoma. J Surg Res. 2015 Dec; 199(2):494-504. Yuen NK, Li CS, Monjazeb AM, Borys D, Bold RJ, Canter RJ. PMID: 26163324; PMCID: PMC4789295.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    83. Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells. Oncoimmunology. 2015 Sep; 4(9):e1036212. Ames E, Canter RJ, Grossenbacher SK, Mac S, Smith RC, Monjazeb AM, Chen M, Murphy WJ. PMID: 26405602; PMCID: PMC4570100.
      View in: PubMed   Mentions: 49     Fields:    
    84. Anthropomorphic Phantoms for Confirmation of Linear Accelerator-Based Small Animal Irradiation. Cureus. 2015 Mar; 7(3):e254. Perks JR, Lucero S, Monjazeb AM, Li JJ. PMID: 26180678; PMCID: PMC4494576.
      View in: PubMed   Mentions: 5  
    85. Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J Exp Med. 2014 Nov 17; 211(12):2373-83. Mirsoian A, Bouchlaka MN, Sckisel GD, Chen M, Pai CC, Maverakis E, Spencer RG, Fishbein KW, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Taub DD, Murphy WJ. PMID: 25366964; PMCID: PMC4235633.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    86. Combining targeted agents with modern radiotherapy in soft tissue sarcomas. J Natl Cancer Inst. 2014 Nov; 106(11). Wong P, Houghton P, Kirsch DG, Finkelstein SE, Monjazeb AM, Xu-Welliver M, Dicker AP, Ahmed M, Vikram B, Teicher BA, Coleman CN, Machtay M, Curran WJ, Wang D. PMID: 25326640; PMCID: PMC4207861.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    87. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. BMC Cancer. 2014 Oct 10; 14:756. Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. PMID: 25301268; PMCID: PMC4200119.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    88. Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis. J Surg Oncol. 2015 Feb; 111(2):158-64. Naing KW, Monjazeb AM, Li CS, Lee LY, Yang A, Borys D, Canter RJ. PMID: 25176165; PMCID: PMC4305005.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    89. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help. PLoS One. 2014; 9(8):e102709. Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, Sckisel GD, Murphy WJ. PMID: 25119341; PMCID: PMC4131875.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    90. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1899-904. Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. PMID: 25064746; PMCID: PMC4254314.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    91. Antitumor effects of cisplatin combined with tecemotide immunotherapy in a human MUC1 transgenic lung cancer mouse model. Cancer Immunol Res. 2014 Jun; 2(6):581-9. Kao CJ, Wurz GT, Monjazeb AM, Vang DP, Cadman TB, Griffey SM, Wolf M, DeGregorio MW. PMID: 24894093.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    92. Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity. Ann Surg Oncol. 2014 May; 21(5):1616-23. Canter RJ, Borys D, Olusanya A, Li CS, Lee LY, Boutin RD, Christensen SD, Tamurian RM, Monjazeb AM. PMID: 24554062; PMCID: PMC4153793.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    93. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med. 2013 Oct 21; 210(11):2223-37. Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ. PMID: 24081947; PMCID: PMC3804937.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansAnimalsCells
    94. Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies. Front Oncol. 2013; 3:197. Monjazeb AM, Zamora AE, Grossenbacher SK, Mirsoian A, Sckisel GD, Murphy WJ. PMID: 23898464; PMCID: PMC3724213.
      View in: PubMed   Mentions: 24  
    95. Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg. 2013 Jul; 148(7):632-9. Wasif N, Smith CA, Tamurian RM, Christensen SD, Monjazeb AM, Martinez SR, Canter RJ. PMID: 23552630.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    96. The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications. Semin Radiat Oncol. 2013 Jan; 23(1):60-73. Monjazeb AM, Blackstock AW. PMID: 23207048.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    97. Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses. PLoS One. 2012; 7(10):e48049. Bouchlaka MN, Sckisel GD, Wilkins D, Maverakis E, Monjazeb AM, Fung M, Welniak L, Redelman D, Fuchs A, Evrensel CA, Murphy WJ. PMID: 23133545; PMCID: PMC3485005.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    98. Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res. 2012 Sep; 32(9):3911-5. Shah D, Borys D, Martinez SR, Li CS, Tamurian RM, Bold RJ, Monjazeb A, Canter RJ. PMID: 22993336; PMCID: PMC4153787.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    99. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. J Immunotoxicol. 2012 Jul-Sep; 9(3):248-58. Monjazeb AM, Hsiao HH, Sckisel GD, Murphy WJ. PMID: 22734880.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    100. The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer. Expert Rev Anticancer Ther. 2012 Apr; 12(4):469-80. Kimple RJ, Russo S, Monjazeb A, Blackstock AW. PMID: 22500684; PMCID: PMC3628691.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):376-82. Yi SK, Mak W, Yang CC, Liu T, Cui J, Chen AM, Purdy JA, Monjazeb AM, Do L. PMID: 22342301.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    102. Treatment of hemoptysis associated with aspergilloma using external beam radiotherapy: A case report and literature review. Pract Radiat Oncol. 2011 Oct-Dec; 1(4):279-81. Samuelian JM, Attia AA, Jensen CA, Monjazeb AM, Blackstock AW. PMID: 24674006.
      View in: PubMed   Mentions: 4     Fields:    
    103. A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):743-8. Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, McMullen KP, Chan MD, Tatter SB, Lesser GJ, Shaw EG. PMID: 21236604; PMCID: PMC4586107.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    104. Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? J Clin Oncol. 2010 Nov 01; 28(31):4714-21. Monjazeb AM, Riedlinger G, Aklilu M, Geisinger KR, Mishra G, Isom S, Clark P, Levine EA, Blackstock AW. PMID: 20876421; PMCID: PMC3020701.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    105. Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements. BMC Cancer. 2010 Mar 31; 10:121. Sanders AM, Stehle JR, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Monjazeb AM, Adams JM, Willingham MC, Cui Z. PMID: 20356394; PMCID: PMC2861034.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    106. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer. Clin Adv Hematol Oncol. 2009 May; 7(5):327-333, 342. Kim C, Monjazeb AM, Suntharalingam M, Giesinger KR, Blackstock AW. PMID: 19521322.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis. 2006 Oct; 27(10):1950-60. Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH. PMID: 16704987.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    108. Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. Prostaglandins Leukot Essent Fatty Acids. 2005 Dec; 73(6):463-74. Monjazeb AM, High KP, Koumenis C, Chilton FH. PMID: 16169197.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    109. Intussusception secondary to metastasis from a low-grade retroperitoneal liposarcoma. Am Surg. 2004 Sep; 70(9):775-8. Monjazeb A, Stanton C, Levine EA. PMID: 15481292.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    110. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. J Lipid Res. 2002 Nov; 43(11):1818-28. Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP. PMID: 12401880.
      View in: PubMed   Mentions: 34     Fields:    Translation:Cells
    111. Antineoplastic properties of arachidonic acid and its metabolites. Prostaglandins Leukot Essent Fatty Acids. 2002 Jan; 66(1):5-12. Monjazeb AM, Clay CE, High KP, Chilton FH. PMID: 12051952.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    Arta's Networks
    Concepts (411)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (82)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California